SI1259513T1 - A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID AND PROCESS THEREFOR - Google Patents

A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID AND PROCESS THEREFOR

Info

Publication number
SI1259513T1
SI1259513T1 SI200130032T SI200130032T SI1259513T1 SI 1259513 T1 SI1259513 T1 SI 1259513T1 SI 200130032 T SI200130032 T SI 200130032T SI 200130032 T SI200130032 T SI 200130032T SI 1259513 T1 SI1259513 T1 SI 1259513T1
Authority
SI
Slovenia
Prior art keywords
pyrrolo
pyrimidin
dihydro
benzoyl
oxo
Prior art date
Application number
SI200130032T
Other languages
English (en)
Slovenian (sl)
Inventor
Erik Christopher Chelius
Susan Marie Reutzel-Edens
Sharon Van Den Berghe Snorek
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22679017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1259513(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI1259513T1 publication Critical patent/SI1259513T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
SI200130032T 2000-02-25 2001-02-12 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID AND PROCESS THEREFOR SI1259513T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18496400P 2000-02-25 2000-02-25
PCT/US2001/001229 WO2001062760A2 (en) 2000-02-25 2001-02-12 A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
EP01906554A EP1259513B1 (en) 2000-02-25 2001-02-12 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR

Publications (1)

Publication Number Publication Date
SI1259513T1 true SI1259513T1 (en) 2003-12-31

Family

ID=22679017

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130032T SI1259513T1 (en) 2000-02-25 2001-02-12 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID AND PROCESS THEREFOR

Country Status (35)

Country Link
US (1) US7138521B2 (cs)
EP (1) EP1259513B1 (cs)
JP (1) JP4846158B2 (cs)
KR (1) KR100744917B1 (cs)
CN (1) CN1183135C (cs)
AR (1) AR029471A1 (cs)
AT (1) ATE249462T1 (cs)
AU (1) AU777047B2 (cs)
BR (1) BR0108604A (cs)
CA (1) CA2400155C (cs)
CO (1) CO5261585A1 (cs)
CZ (1) CZ303772B6 (cs)
DE (1) DE60100750T2 (cs)
DK (1) DK1259513T3 (cs)
DZ (1) DZ3283A1 (cs)
EA (1) EA004684B1 (cs)
EG (1) EG24073A (cs)
ES (1) ES2206403T3 (cs)
HR (1) HRP20020701B1 (cs)
HU (1) HU229704B1 (cs)
IL (2) IL150480A0 (cs)
MX (1) MXPA02008242A (cs)
MY (1) MY124784A (cs)
NO (1) NO323422B1 (cs)
NZ (1) NZ519796A (cs)
PE (1) PE20011082A1 (cs)
PL (1) PL208061B1 (cs)
PT (1) PT1259513E (cs)
SI (1) SI1259513T1 (cs)
SK (1) SK287375B6 (cs)
SV (1) SV2002000321A (cs)
TW (1) TWI237024B (cs)
UA (1) UA72791C2 (cs)
WO (1) WO2001062760A2 (cs)
ZA (1) ZA200205265B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100364993C (zh) * 2003-05-30 2008-01-30 江苏恒瑞医药股份有限公司 培美曲噻盐及其制备方法
CN100364994C (zh) * 2004-11-25 2008-01-30 重庆医药工业研究院有限责任公司 培美曲塞二钠的一种新晶型及其制备方法
AU2006311808A1 (en) * 2005-11-04 2007-05-18 Merck Sharp & Dohme Corp. Methods of using SAHA and bortezomib for treating cancer
CA2622136A1 (en) * 2005-11-04 2007-05-18 Merck & Co., Inc. Methods of using saha and erlotinib for treating cancer
ES2356792T3 (es) 2006-08-14 2011-04-13 Sicor, Inc. Procedimientos para la preparación de sales farmacéuticamente aceptables liofilizadas de pemetrexed diácido.
EP1934226A2 (en) * 2006-08-14 2008-06-25 Sicor, Inc. Highly pure pemetrexed diacid and processes for the preparation thereof
EP2305681A1 (en) * 2006-08-14 2011-04-06 Sicor, Inc. Crystalline form of pemetrexed diacid and process for the preparation thereof
JP2008543973A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド ペメトレキセドの中間体の調製方法
CA2667348A1 (en) * 2006-11-03 2008-05-15 University Of Maryland, Baltimore Methods of using saha and bortezomib for treating multiple myeloma
KR20100014854A (ko) 2007-04-03 2010-02-11 닥터 레디스 레보러터리즈 리미티드 페메트렉세드의 고체 형태
CN101417998B (zh) 2007-10-24 2012-10-24 重庆医药工业研究院有限责任公司 一种培美曲塞盐的纯化方法
EP2072518A1 (en) * 2007-12-23 2009-06-24 Sun Pharma Advanced Research Company Limited Stable Amorphous Form of Pemextred Disodium
WO2010028105A2 (en) * 2008-09-08 2010-03-11 Dr. Reddy's Laboratories Ltd. Amorphous pemetrexed disodium
WO2010030598A2 (en) * 2008-09-11 2010-03-18 Dr. Reddy's Laboratories Limited Pharmaceutical formulations comprising pemetrexed
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
CN102050825B (zh) * 2009-11-05 2014-12-17 上海创诺制药有限公司 制备培美曲塞二钠2.5水结晶的方法
US9174991B2 (en) 2009-11-24 2015-11-03 Azad Pharmaceutical Ingredients Ag Crystalline form of pemetrexed disodium
CN102372719B (zh) * 2010-08-26 2013-10-30 齐鲁制药有限公司 培美曲塞二甲酯对甲苯磺酸盐晶型及其制备方法
KR101069128B1 (ko) * 2011-03-10 2011-09-30 건일제약 주식회사 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법
US9051322B2 (en) 2011-03-23 2015-06-09 Scinopharm Taiwan, Ltd. Process for the production of a pemetrexed salt
KR101767713B1 (ko) 2011-03-25 2017-08-11 시노팜 타이완 리미티드 페메트렉세드 염의 제조 방법
ITRM20120398A1 (it) 2012-08-08 2014-02-09 Berlin Chemie Ag Procedimento di sintesi pemetrexed e suo sale di lisina.
CN102911176B (zh) * 2012-10-10 2015-07-22 德州德药制药有限公司 一种培美曲塞二钠的制备方法
WO2014060959A1 (en) * 2012-10-17 2014-04-24 Shilpa Medicare Limited Crystalline pemetrexed dipotassium process
WO2014122460A2 (en) 2013-02-06 2014-08-14 Cipla House Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes
WO2014167585A1 (en) 2013-04-12 2014-10-16 Actavis Group Ptc Ehf. Pemetrexed formulation
KR101485243B1 (ko) 2013-05-08 2015-01-21 씨제이헬스케어 주식회사 안정화된 페메트렉시드 제제
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
WO2014198338A1 (en) 2013-06-14 2014-12-18 Synthon B.V. Stable pemetrexed arginine salt and compositions comprising it
JP2016527227A (ja) 2013-07-16 2016-09-08 ドクター レディズ ラボラトリーズ リミテッド ペメトレキセドトロメタミン塩の新規な結晶形
EP3040074B1 (en) 2013-10-03 2018-07-25 Fujifilm Corporation Injection preparation and method for producing same
NZ630292A (en) * 2013-11-25 2015-02-27 Shilpa Medicare Ltd Process for crystalline pemetrexed dipotassium salt
NZ630299A (en) 2014-06-30 2014-11-28 Shilpa Medicare Ltd Pemetrexed dipotassium formulations
CA2962383C (en) 2014-10-30 2019-10-08 Scinopharm Taiwan, Ltd. Crystalline forms of pemetrexed diacid and manufacturing processes therefor
CN105566328B (zh) * 2014-11-06 2018-04-24 博瑞生物医药（苏州）股份有限公司 培美曲塞二酸多晶型的制备方法
US20190105262A1 (en) * 2017-10-10 2019-04-11 Sun Pharmaceutical Industries Ltd. Intravenous infusion dosage form for pemetrexed

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
KR0162654B1 (ko) * 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
EP0923287A4 (en) * 1996-08-30 2001-08-01 Lilly Co Eli NON-CLASSIC PYRROLO (2,3-D) PYRIMIDINE ANTIFOLATE
ZA987550B (en) * 1997-09-26 2000-02-21 Lilly Co Eli Processes and intermediates useful to make antifolates.
PL196216B1 (pl) * 1997-09-26 2007-12-31 Lilly Co Eli Sposób wytwarzania 5-podstawionych związków pirolo[2,3-d]pirymidyny
WO2001014379A2 (en) * 1999-08-23 2001-03-01 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor

Also Published As

Publication number Publication date
MXPA02008242A (es) 2002-11-29
ZA200205265B (en) 2003-11-11
EP1259513B1 (en) 2003-09-10
ATE249462T1 (de) 2003-09-15
CN1183135C (zh) 2005-01-05
JP4846158B2 (ja) 2011-12-28
JP2003530321A (ja) 2003-10-14
US7138521B2 (en) 2006-11-21
DE60100750T2 (de) 2004-07-29
CA2400155A1 (en) 2001-08-30
BR0108604A (pt) 2002-11-19
HK1051856A1 (en) 2003-08-22
CZ303772B6 (cs) 2013-05-02
SK287375B6 (sk) 2010-08-09
KR20020075449A (ko) 2002-10-04
NO20023974D0 (no) 2002-08-21
HU229704B1 (en) 2014-05-28
EA200200905A1 (ru) 2003-02-27
KR100744917B1 (ko) 2007-08-01
EG24073A (en) 2008-05-11
SK11862002A3 (sk) 2003-01-09
CN1406238A (zh) 2003-03-26
WO2001062760A2 (en) 2001-08-30
PE20011082A1 (es) 2001-10-22
EP1259513A2 (en) 2002-11-27
PL356423A1 (en) 2004-06-28
DK1259513T3 (da) 2004-01-12
CA2400155C (en) 2009-09-15
HRP20020701A2 (en) 2003-12-31
PL208061B1 (pl) 2011-03-31
AR029471A1 (es) 2003-07-02
CO5261585A1 (es) 2003-03-31
UA72791C2 (uk) 2005-04-15
NO20023974L (no) 2002-08-21
IL150480A (en) 2007-12-03
CZ20022875A3 (cs) 2003-02-12
HRP20020701B1 (en) 2011-02-28
EA004684B1 (ru) 2004-06-24
NO323422B1 (no) 2007-04-30
MY124784A (en) 2006-07-31
SV2002000321A (es) 2002-07-16
IL150480A0 (en) 2002-12-01
PT1259513E (pt) 2004-02-27
US20030216416A1 (en) 2003-11-20
NZ519796A (en) 2003-01-31
AU777047B2 (en) 2004-09-30
HUP0204232A2 (hu) 2003-04-28
DZ3283A1 (fr) 2001-08-30
DE60100750D1 (de) 2003-10-16
AU3445101A (en) 2001-09-03
ES2206403T3 (es) 2004-05-16
HUP0204232A3 (en) 2006-01-30
TWI237024B (en) 2005-08-01
WO2001062760A3 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
SI1259513T1 (en) A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID AND PROCESS THEREFOR
IL202582A0 (en) New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
AU6890800A (en) A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-D]- pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
AP2002002456A0 (en) Pyrazolo '4,3-d pyrimidine derivatives
PT1382339E (pt) Composições que contêm derivados de pirrolo[2,3-d]- pirimidina
IL225893A0 (en) New triazolo pyrimidine compounds
SG87148A1 (en) Process for producing acrolein and acrylic acid
PL362922A1 (en) Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines
IL144516A0 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO [4,3-d] PYRIMIDIN-7-ONE COMPOUNDS AND INTERMEDIATES THEREOF
AU7644498A (en) Method for producing granulates with a long shelf life containing soil release polymers and the use thereof for the production of solid detergents and cleaning agents
MY122760A (en) Substantially crystalline form of melagatran
PL370067A1 (en) 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
AU5425000A (en) Formulation useful as a nitrification and urease inhibitor and a method of producing the same
PL363077A1 (en) Use of pyrazolo[4,3-d]pyrimidines
PL361890A1 (en) Use of pyrazolo[4,3-d]pyrimidines
IL138913A0 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one-3-pyridylsulphonyl compounds and intermediates thereof
GB2363377B (en) Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof
EP1570049A4 (en) 5-XANTHYLSURE PRODUCING MICROORGANISM
AU2002219636A1 (en) Microorganism producing 5'-inosinic acid and process for producing 5'-inosinic acid using the same
AU2002328088A8 (en) Crystalline aluminophosphate production process and crystalline aluminophosphate
PL338759A1 (en) Novel diethylammonic derivatives of beta-(3,5)-di-t-butyl-4-hydroxy) phenylpropionic acid aminoester
GB0221515D0 (en) A novel process for the preparation of 3,3'-azo-bis (6-hydroxybenzoic acid) and its derivatives
GB0110251D0 (en) Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof
AU2001242369A1 (en) Manufacturing process for the preparation of alpha,alpha,alpha',alpha'-branched dicarboxylic acids
AU2001275934A1 (en) 32529, a novel human guanine nucleotide exchange factor family member and uses thereof